Abstract
The prognostic factors for myelodysplastic syndromes (MDS) can be classified into clinical, morphological, cytogenetic, in vitro culture characteristics and the oncogene data which have recently become available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Appelbaum FR, Storb R, Ramberg RE, Shulmann HM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Sanders J, Stewart P, Sullivan K, Witherspoon R, Thorns ED (1987) Treatment of preleukemic syndromes with marrow transplantation. Blood 69: 92–96
Armitage JO, Dick FR, Needleman SW, Burns CP (1981) Effect of chemotherapy for the dysmyelopoietic syndrome. Cancer Treat Rep 65: 601–605
Cazzola AM, Barosi G. Berzuini, Dacco M. Orlandi D, Stefanelli M, Ascari B (1982) Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol 50: 55–62
Cheson BD, Jasperse DM, Simon R, Friedman MA (1986) A critical appraisal of low-dose cytosin arabinoside in patients with acute non-lymphatic leukaemina and myelodysplastic syndromes. J Clin Oncol 4: 1857–1864
Mufti GJ, Stevens JR, Oscier DG et al. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59: 425–433
Pierre RV, Catovsky D, Mufti GJ et al. (1988) Clinical-cytogenetic correlations in myelodysplasia (preleukaemia). In: Report of the 6th International Workshop on Chromosomes in Leukaemia. London 1987. Cancer Genet Cytogenet 40: 149–161
Tricot GJK, Verwilghen RL (1986) Prognostic factors in the myelodysplastic syndromes. Scand J Haematol [Supp 45] 36: 107–113
Varella BL, Chuang C, Woll JE et al. (1985) Modifications in the classification of primary myelodysplastic syndrome; the addition of a scoring system. Hematol Oncol 3: 55–63
Worsley A, Oscier DG, Stevens J et al (1988) Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol 68: 17–21
Yoshida Y, Oguma S, Uchino H, Maekawa T (1988) Haematological and prognostic variability of refractory anemias. Blut 56: C11 (Proceedings 1st international Symposium on MDS)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mufti, G.J. (1992). Therapeutic Implications of Understanding Pathogenesis: Clinical Relevance of Prognostic Factors. In: Schmalzl, F., Mufti, G.J. (eds) Myelodysplastic Syndromes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75952-9_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-75952-9_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52966-8
Online ISBN: 978-3-642-75952-9
eBook Packages: Springer Book Archive